Makeup
BB & CC Creams
Blushers
Brushes & Tools
Concealers
Contouring Products
Eye Brow Products
Eye Primers
Eye Shadows
Face & Body Glitter
Face Powders
Face Primers
False Nails
Foundations
Highlighters
Lash Primers
Lash Products
Lip Glosses
Lip Liners
Lip Plumping Products
Lipsticks
Makeup Palettes
Makeup Setting Sprays
Nail Care Products
Nail Laquers
Randoms
Subscription Boxes
Skin Care
Anti Ageing Creams
Bath & Shower Products
Body Exfoliants
Body Moisturisers
Cleansers
Exfoliants & Masks
Eye Care Products
Face Moisturisers
Fake Tan Products
Foot Care Products
Hair Removal Products
Hand Care Products
Lip Care Products
Perfumes
Problem Skin Care Products
Sun Care Products
Toners
Hair Care
Conditioners
Hair Brushes & Accessories
Hair Colour Products
Hair Protection Products
Hair Styling Products
hair_treatment_and_masks
Heated Styling Tools
Scalp Care
Shampoos
Gift
Gift Sets
Targeted breakout corrector for individual blemishes. SPECIFICALLY FORMULATED FOR: Specifically formulated for oily, blemish-prone skin. An easy-to-apply, quickly absorbed, targeted SOS treatment to help reduce the appearance of localised imperfections and blemishes and prevent residual marks. Fights against the cause of the imperfection and activates the skin's regeneration process. Suitable for sensitive skin. Targets individual blemishes For oily skin and sensitive skin prone to breakouts Helps prevent residual marks from acne ACTIVE Enriched with Niacinamide, Piroctone Olamine and LHA DERMATOLOGICALLY TESTED Effaclar has been through rigorous dermatological testing to ensure it is suitable for use on even the most sensitive skin. 9/10 dermatologists would recommend La Roche-Posay Effaclar for oily, blemish-prone skin. MINIMALIST HYPO-ALLERGENIC FORMULA The minimalist formula contains the best of our creations – designed for sensitive skin and all of its needs. Tested and re-tested for its efficacy and mildness on sensitive skin. It is also hypoallergenic. This is a cosmetic product. For medical conditions seek advice from your GP Survey conducted on 249 dermatologists who chose to attend a La Roche-Posay sponsored symposium in the UK, July 2016